Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data

References

• AlbertiKGZimmetPZDefinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultationDiabet Med199815539539686693
   PubMed Web of Science ®Google Scholar
• AnthenelliRMDaleLRimonabant helps cigarette smokers stop smoking and prevents post cessation weight gain: results from the STRATUS-US trial [abstract]2004Final program and abstracts of 6th Annual Conference of the SRNT EuropeOctober 6–9, 2004Tubingen, Germanyp 39
   Google Scholar
• BensaidMGary-BoboAEsclangonJThe cannabinoid CB-1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cellsMol Pharmacol2003639081412644592
   PubMed Web of Science ®Google Scholar
• ChandranMPhillipsSACiaraldiTAdiponectin: more than just another fat cell hormone?Diabetes Care20032624425012882876
   PubMed Web of Science ®Google Scholar
• CotaDMarsicanoGTschöpMThe endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesisJ Clin Invest20031124233112897210
   PubMed Web of Science ®Google Scholar
• CravattBFGiangDKMayfieldSPMolecular characterization of an enzyme that degrades neuromodulatory fatty-acid amidesNature19963848378900284
   PubMed Web of Science ®Google Scholar
• De PetrocellisLCascioMGDi MarzoVThe endocannabinoid system: a general view and latest additionsBr J Pharmacol20041417657414744801
   PubMed Web of Science ®Google Scholar
• DesprésJPGolayASjostromLRimonabant in Obesity-Lipids Study GroupEffects of rimonabant on metabolic risk factors in overweight patients with dyslipidemiaN Engl J Med2005353212113416291982
   PubMed Web of Science ®Google Scholar
• DiSMalcher-LopesRHalmosKCNongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanismJ Neurosci20032348505712832507
   PubMed Web of Science ®Google Scholar
• DinhTPCarpenterDLeslieFMBrain monoglyceride lipase participating in endocannabinoid inactivationProc Natl Acad Sci USA200299108192412136125
   PubMed Web of Science ®Google Scholar
• Di MarzoVGoparajuSKWangLLeptin-regulated endocannabinoids are involved in maintaining food intakeNature2001410822511298451
   PubMed Web of Science ®Google Scholar
• Di MarzoVMatiasIEndocannabinoid control of food intake and energy balanceNature Neurosci20058585915856067
   PubMed Web of Science ®Google Scholar
• EngeliSBohnkeJFeldpauschMActivation of the peripheral endocannabinoid system in human obesityDiabetes20055428384316186383
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in AdultsExecutive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• FordESGilesWHMokdadAHIncreasing prevalence of the metabolic syndrome among US AdultsDiabetes Care2004272444915451914
   PubMed Web of Science ®Google Scholar
• GaddeKMAllisonDBCannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risksCirculation20061149748416940206
   PubMed Web of Science ®Google Scholar
• GomezRNavarroMFerrerBA peripheral mechanism for CB-1 cannabinoid receptor-dependent modulation of feedingJ Neurosci20022296121712417686
   PubMed Web of Science ®Google Scholar
• GrundySMBrewerHBCleemanJIDefinition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific IssuesCirculation200410943343814744958
   PubMed Web of Science ®Google Scholar
• HervaALaitinenJMiettunenJObesity and depression: results from the longitudinal Northern Finland 1966 Birth Cohort StudyInt J Obes (Lond)200630520716302014
   PubMed Web of Science ®Google Scholar
• HowlettACBarthFBonnerTIInternational Union of Pharmacology XXVII. Classification of cannabinoid receptorsPharmacol Rev20025416120212037135
   PubMed Web of Science ®Google Scholar
• KershawEEFlierJSAdipose tissue as an endocrine organJ Clin Endocrinol Meta200489254856
   PubMed Web of Science ®Google Scholar
• KirkhamTCWilliamsCMFezzaFEndocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerolBr J Pharmacol20021365505712055133
   PubMed Web of Science ®Google Scholar
• LakkaHMLaaksonenDELakkaTAThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged menJAMA200228827091612460094
   PubMed Web of Science ®Google Scholar
• LiuYLConnoleyIPWilsonCAEffects of the cannabinoid CB-1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) miceInt J Obes Relat Metab Disord2005291837
   PubMed Web of Science ®Google Scholar
• LorenzoCOkoloiseMWilliamsKThe metabolic syndrome as predictor of type 2 diabetes. the San Antonio Heart StudyDiabetes Care2003263153914578254
   PubMed Web of Science ®Google Scholar
• MartinMLedentCParmentierMInvolvement of CB1 cannabinoid receptors in emotional behaviourPsychopharmacology20021593798711823890
   PubMed Web of Science ®Google Scholar
• Osei-HyiamanDDepetrilloMPacherPEndocannabinoid activation at hepatic CB-1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesityJ Clin Invest20051151298130515864349
   PubMed Web of Science ®Google Scholar
• PiomelliDThe molecular logic of endocannabinoid signallingNat Rev Neurosci200348738414595399
   PubMed Web of Science ®Google Scholar
• Pi-SunyerFXAronneLJHeshmatiHMEffect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trialJAMA20062957617516478899
   PubMed Web of Science ®Google Scholar
• Ravinet TrillouCArnoneMDelgorgeCAnti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese miceAm J Physiol Regul Integr Comp Physiol2003284R3455312399252
   PubMed Web of Science ®Google Scholar
• Ravinet TrillouCDelgorgeCMenetCCB-1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivityInt J Obes2004286408
   PubMed Web of Science ®Google Scholar
• Sanofi AventisSanofi-aventis received from the FDA an approvable letter for rimonabant for weight management and a non approvable letter for smoking cessation [online]2006 Accessed 3 Nov 2006. URL: http://en.sanofi-aventis.com/press/p_press_2006.asp
   Google Scholar
• ScheenAJFinerNHollanderPEfficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled studyLancet200636816607217098084
   PubMed Web of Science ®Google Scholar
• SipeJCWaalenJGerberAOverweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)Int J Obes200529755769
   PubMed Web of Science ®Google Scholar
• TurpaultSKanamaluruVLockwoodGFRimonabant pharmacokinetics in healthy and obese subjects [abstract]Clin Pharmacol Ther200679Suppl 250
   Web of Science ®Google Scholar
• Van GaalLFRissanenAMScheenAJRIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular factors in overweight patients: 1year experience from the RIO-Europe studyLancet200536513899715836887
   PubMed Web of Science ®Google Scholar
• VickersSPWebsterLJWyattAPreferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker ratsPsychopharmacology20031671031112632249
   PubMed Web of Science ®Google Scholar
• World Health OrganizationObesity and overweight [online]2006a Accessed 30 Oct 2006. URL: http://www.who.int/mediacentre/fact-sheets/fs311/en/
   Google Scholar
• World Health OrganizationObesity and overweight [online]2006b Accessed 3 Nov 2006. URL: http://www.who.int/dietphysicalactiv-ity/publications/facts/obesity/en/
   Google Scholar
• ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand198367361706880820
   PubMed Web of Science ®Google Scholar